102 related articles for article (PubMed ID: 21268730)
1. Tackling the Achilles' heel of hemodialysis.
Winkelmayer WC
N Engl J Med; 2011 Jan; 364(4):372-4. PubMed ID: 21268730
[No Abstract] [Full Text] [Related]
2. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.
Hemmelgarn BR; Moist LM; Lok CE; Tonelli M; Manns BJ; Holden RM; LeBlanc M; Faris P; Barre P; Zhang J; Scott-Douglas N;
N Engl J Med; 2011 Jan; 364(4):303-12. PubMed ID: 21268722
[TBL] [Abstract][Full Text] [Related]
3. Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial.
Gittins NS; Hunter-Blair YL; Matthews JN; Coulthard MG
Arch Dis Child; 2007 Jun; 92(6):499-501. PubMed ID: 17068072
[TBL] [Abstract][Full Text] [Related]
4. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
5. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
[TBL] [Abstract][Full Text] [Related]
6. Dialysis catheters and recombinant tissue plasminogen activator.
Allon M
N Engl J Med; 2011 May; 364(18):1779; author reply 1779-80. PubMed ID: 21542758
[No Abstract] [Full Text] [Related]
7. Alteplase for the management of occluded central venous access devices: safety considerations.
Smith LH
Clin J Oncol Nurs; 2008 Feb; 12(1):155-7. PubMed ID: 18258586
[No Abstract] [Full Text] [Related]
8. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
[TBL] [Abstract][Full Text] [Related]
9. Revisiting quality standards in hemodialysis vascular access: where is the bar?
Thomas A
CANNT J; 2005; 15(4):30-3, 36-41; quiz 34-5. PubMed ID: 16491996
[TBL] [Abstract][Full Text] [Related]
10. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters.
Castner D
Nephrol Nurs J; 2001 Aug; 28(4):403-4, 407-10. PubMed ID: 12143462
[TBL] [Abstract][Full Text] [Related]
12. The urokinase lock-therapy for hemodialysis occluded central venous catheters.
Li Cavoli G; Schillaci O; Zagarrigo C; Servillo F; Li Cavoli TV; Palmeri M; Rotolo U
Blood Purif; 2015; 39(1-3):238. PubMed ID: 25823425
[No Abstract] [Full Text] [Related]
13. Tissue plasminogen activator as a hemodialysis catheter locking solution.
McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
[TBL] [Abstract][Full Text] [Related]
14. [Certain complications caused by the use of external arteriovenous shunt and internal arteriovenous fistula in patients with terminal renal insufficiency kept on regular hemodialysis].
Ermolenko VM; Polevikov VV
Sov Med; 1974 Nov; (11):72-7. PubMed ID: 4612749
[No Abstract] [Full Text] [Related]
15. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
Jacobs BR; Haygood M; Hingl J
J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
[TBL] [Abstract][Full Text] [Related]
16. Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.
Jonker MA; Osterby KR; Vermeulen LC; Kleppin SM; Kudsk KA
JPEN J Parenter Enteral Nutr; 2010; 34(4):444-9. PubMed ID: 20631392
[TBL] [Abstract][Full Text] [Related]
17. Combination thrombolytic and anticoagulant therapy for bilateral renal vein thrombosis in a premature infant.
Weinschenk N; Pelidis M; Fiascone J
Am J Perinatol; 2001 Aug; 18(5):293-7. PubMed ID: 11552182
[TBL] [Abstract][Full Text] [Related]
18. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
19. Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter.
Cachat F; Bardy D; Durussel C; Di Paolo E
Pediatr Nephrol; 2006 Feb; 21(2):301-2. PubMed ID: 16328539
[TBL] [Abstract][Full Text] [Related]
20. [In situ fibrinolysis of acute arteriovenous shunt obstructions during hemodialysis].
Jahn C; Lebras Y; Mutter D; Petitjean P; Roy C; Schnitzler B; Dimitrov Y
Nephrologie; 1994; 15(2):145-50. PubMed ID: 8047201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
